These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9474020)

  • 1. Increased concentrations of serum pentosidine in rheumatoid arthritis.
    Rodríguez-García J; Requena JR; Rodríguez-Segade S
    Clin Chem; 1998 Feb; 44(2):250-5. PubMed ID: 9474020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.
    Senolt L; Braun M; Vencovský J; Sedová L; Pavelka K
    Physiol Res; 2007; 56(6):771-777. PubMed ID: 17298211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.
    Hein GE; Köhler M; Oelzner P; Stein G; Franke S
    Rheumatol Int; 2005 Dec; 26(2):137-41. PubMed ID: 15580352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
    Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
    Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
    Nowak A; Przywara-Chowaniec B; Damasiewicz-Bodzek A; Blachut D; Nowalany-Kozielska E; Tyrpień-Golder K
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis.
    Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    Br J Rheumatol; 1997 Jun; 36(6):637-42. PubMed ID: 9236672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis.
    Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    J Rheumatol; 1998 Dec; 25(12):2440-4. PubMed ID: 9858442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.
    O'Grady KL; Khosla S; Farr JN; Bondar OP; Atkinson EJ; Achenbach SJ; Eckhardt BA; Thicke BS; Tweed AJ; Volkman TL; Drake MT; Hines JM; Singh RJ
    J Appl Lab Med; 2020 May; 5(3):558-568. PubMed ID: 32445362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis.
    Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    Rheumatology (Oxford); 1999 Dec; 38(12):1275-8. PubMed ID: 10587559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy.
    Raj DS; Lim G; Levi M; Qualls C; Jain SK
    Am J Kidney Dis; 2004 Jan; 43(1):154-60. PubMed ID: 14712439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis.
    Vytásek R; Sedová L; Vilím V
    BMC Musculoskelet Disord; 2010 May; 11():83. PubMed ID: 20433772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
    Misselwitz J; Franke S; Kauf E; John U; Stein G
    Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentosidine and its deposition in renal tissue in renal transplantation.
    Yoshida K; Yoneda T; Fujimoto K; Hirao Y; Konishi N
    Transplant Proc; 2005 Dec; 37(10):4266-72. PubMed ID: 16387094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
    Yoshida N; Okumura K; Aso Y
    Metabolism; 2005 Mar; 54(3):345-50. PubMed ID: 15736112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
    Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
    Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
    Kerkeni M; Saïdi A; Bouzidi H; Ben Yahya S; Hammami M
    Microvasc Res; 2012 Nov; 84(3):378-83. PubMed ID: 22835520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.